Identifíquese
¿Aún no es suscriptor de la revista?
Comprar el acceso al artículo
Comprando el artículo el pdf del mismo podrá ser descargado
Teléfono para incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Bibliografía
[1]
Hricick DE, Monja Cheng-Park M, Sedor JR..
Glomerulonephritis..
N Engl J Med, (1998), 339 pp. 888-99
[2]
Holm SE..
The pathogenesis of acute post-streptococcal glomerulonephritis in new lights..
APMIS, (1988), 96 pp. 189-93
[3]
Sorger K, Gessler M, Hubner FK, Kohler H, Ulbing H, Schulz W, et al..
Follow-up studies of three subtypes of acute postinfectious glomerulonephritis ascertained by renal biopsy..
Clin Nephrol, (1987), 27 pp. 111-24
[4]
Kozyro I, Perahud I, Sadallah S, Sukalo A, Titou L, Schifferli J, et al..
Clinical value of autoantibodies against C1q in children with glomerulonephritis..
Pediatrics, (2006), 117 pp. 1663-8
[5]
Acute endocapillary glomerulonephritis En: Davison AM, Cameron JS, Grünfeld JP, Ponticelli C, Ritz E, Winearls CG, et al, editors. Oxford textbook of clinical nephrology. 3th ed. Oxford: Oxford Medical Publications; 2005. p. 544-57.
[6]
Isolated glomerular diseases: acute glomerulonephritis. En: Holliday MA, Barrat TM, Vernier RL, editors. Pediatric Nephrology. 2nd ed. Baltimore: Williams and Wilkins; 1987:407-19.
[7]
Pauker SG, Kopelman RI..
Clinical Problem-Solving..
N Engl J Med, (1992), 327 pp. 1366-9
[8]
Case records of the Massachusetts General Hospital (Case 12-1995)..
N Engl J Med, (1995), 332 pp. 1083-9
[9]
Yoshizawa N, Suzuki Y, Oshima S, Takeuchi A, Kondo S, Ishida A, et al..
Asymptomatic acute poststreptococcal glomerulonephritis following upper respiratory tract infections caused by Group A Streptococci..
Clin Nephrol, (1996), 46 pp. 296-301
[10]
Lewy JE, Salinas-Madrigal L, Herdson PB, Pirani CL, Metcoff J..
Clinico-pathologic correlations in acute poststreptococcal glomerulonephritis. A correlation between renal functions, morphologic damage and clinical course of 46 children with acute poststreptococcal glomerulonephritis..
Medicine (Baltimore), (1971), 50 pp. 453-501
[11]
Ferrario F, Kourilsky O, Morel-Maroger L..
Acute endocapillary glomerulonephritis in adults: A histologic and clinical comparison between patients with and without acute renal faillure..
Clin Nephrol, (1983), 19 pp. 17-23
[12]
Yoshizawa N, Fujino M, Oda T, Tamura K, Matsumoto K, Sugisaki T, et al..
Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: Characterization of the antigen and associated immune response..
J Am Soc Nephrol, (2004), pp. 1785-93
[13]
Sesso R, Wyton S, Pinto L..
Epidemic glomerulonephritis due to Streptococcus zooepidermicus in Nova Serrana, Brazil..
Kidney Int Suppl, (2005), 97 pp. S132-S6
[14]
Montseny JJ, Meyrier A, Kleinknecht D, Callard P..
The current spectrum of infectious glomerulonephritis. Experience with 76 patients and review of the literature..
Medicine (Baltimore), (1995), 74 pp. 63-73
[15]
Natural history of poststreptococcal glomerulonephritis. En: Zabriskie JB, Read SE, editors. Streptococcal diseases and the immune response. New York: Academic Press; 1980. p. 56379.
[16]
Potter EV, Lipschultz SA, Abidh S, Poon King T, Earle DP..
Twelve to seventeen year follow-up of patients with poststreptococcal acute glomerulonephritis in Trinidad..
N Eng J Med, (1982), 307 pp. 725-9
[17]
Kasahara T, Hayakawa H, Okubo S, Okugawa T, Kabuki N, Tomizawa S, et al..
Prognosis of acute poststreptococcal glomerulonephritis is excellent in children when adequately diagnosed..
Pediatr Int, (2001), 43 pp. 364-7
[18]
Tejani A, Ingulli E..
Poststreptococcal glomerulonephritis: current clinical and pathologic concepts..
Nephron, (1990), 55 pp. 1-5
[19]
Roy S II.I, Pitcock JA, Etteldorf JN..
Prognosis of acute poststreptococcal glomerulonephritis in childhood: prospective study and review of the literature..
Adv Pediatr, (1976), 23 pp. 35-69
[20]
Course of poststreptococcal glomerulonephritis. En: UpToDate, Rose BD, editor, UpToDate, Waltham MA, 2006.
[21]
Herrera J, Rodríguez-Iturbe B..
End-stage renal disease and acute glomerulonephritis in Goajiro indians..
Kidney Int Suppl, (2003), 83 pp. S22-6
[22]
Leonard CD, Nagle RB, Striker GE, Cutler RE, Scribner BH..
Acute glomerulonephritis with prolonged oliguria. An analysis of 29 cases..
Ann Intern Med, (1970), 73 pp. 703-11
[23]
Srivastava RN, Mouqdil A, Bagga A, Vasudev AS, Bhuyan UN, Sundraem KR..
cases Am J Nephrol, (1992), 2 pp. 155-61
[24]
Washio M, Oh Y, Okuda S, Yanase T, Mihishima C, Fujimi S, et al..
Clinicopathological study of poststreptococcal glomerulonephritis in the elderly..
Clin Nephrol, (1994), 41 pp. 265-70
[25]
Melby PC, Musick WD, Luger AM, Khanna R..
Poststreptococcal glomerulonephritis in the elderly. Report of a case and review of the literature..
Am J Nephrol, (1987), 7 pp. 235-40
[26]
Deteoglu IO, Springale JE, Waz WR, Stapleton FB, Feld LG..
Prolonged hypocomplementemia in poststreptococcal acute glomerulonephritis..
Clin Nephrol, (1996), 46 pp. 302-5
[27]
Couser WG..
Rapidly progressive glomerulonephritis: Classification, pathogenetic mechanisms, and therapy..
Am J Kidney Dis, (1988), 11 pp. 449-64
[28]
Rapidly progressive glomerulonephritis. En: Schrier RW, Gottschalk CW, editors. Diseases of the kidney. 6th ed. Boston: Little Brown; 1997. p. 1619-44.
[30]
Glomerulonefritis extracapilares. En: Hernando L, Aljama P, Arias M, Caramelo C, Egido J, Lamas S, editores. Nefrología clínica. 2.a ed. Madrid: Editorial Médica Panamericana; 2003. p. 315-21.
[31]
Haas M, Eustace JA..
Inmune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases..
Kidney Int, (2004), 65 pp. 2145-52
[32]
Crescentic glomerulonephritis. En: Ponticelli and Glassock RJ, editors. Treatment of primary glomerulonephritis. 1.a ed. Oxford: Oxford Medical Publications; 1999. p. 234-54.
[33]
Niles JL, Bottinger EP, Saurina GR, Kelly KJ, Pan G, Collins AB, et al..
The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition..
Arch Intern Med, (1996), 156 pp. 440-5
[34]
Introduction to glomerular disease: pathogenesis and classification. En: Johnson RJ, Feehally J, editors. Comprehensive clinical nephrology. 2nd ed. Edinburg: Mosby; 2003. p. 243-53.
[35]
Thomson NM, Moran J, SimpsonI JP, Peters DK..
Defibrination with ancrod in nephrotoxic nephritis in rabbits..
Kidney Int, (1976), 10 pp. 343-7
[36]
Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY..
Modulators of crescentic glomerulonephritis..
J Am Soc Nephrol, (1996), 7 pp. 2271-8
[37]
Rivera F, López-Gomez JM, Pérez-García R..
Spanish registry of glomerulonephritis. Clinicopathologic correlations of renal pathology in Spain..
Kidney Int, (2004), 66 pp. 898-904
[38]
The long-term outcome of glomerular disease. En: Schrier R, Gottshalk C, editors. Disease of the kidney. 5th ed. Boston: Little Brown; 1993. p. 1929-35.
[39]
Hogan SL, Nachman PH, Wilkman AS, Jenette JC, Falk RJ..
Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis..
J Am Soc Nephrol, (1996), 7 pp. 23-32
[40]
Jenette JC..
Rapidly progressive crescentic glomerulonephritis..
Kidney Int, (2003), 63 pp. 1164-77
[41]
Serra A, Martínez-Ocaña JC..
Vasculitis con afectación renal predominante en pacientes mayores de 65 años..
Nefrología, (1997), XVIISupl3 pp. 51-9
[42]
Johnson JP, Moor JJ, Austin HB, Balow JE, Antonovych TT, Wilson CB..
Therapy of anti-glomerular basement membrane antibody disease: Analysis of prognostic significance of clinical, pathologic and treatment factors..
Medicine (Baltimore), (1985), 64 pp. 219-27
[43]
Jindal KK..
Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: Evidence-based recommendations..
Kidney Int, (1999), 70 pp. S33-40
[44]
Jayne D, Ramussen N, Andrasy K, Bacon P, Tervaert JW.C, Dadoniene J, et al; European Vasculitis Study Group..
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies..
N Engl J Med, (2003), 349 pp. 36-44
[45]
Choi MJ, Eustace JA, Giménez LF, Atta MG, Scheel PJ, Sothinathan R..
Mycophenolate mofetil treatment for primary glomerular disease..
Kidney Int, (2002), 61 pp. 1098-14
